Unlimited

Authorized users

Can lend chapters, not whole ebooks

Human iPSC-derived disease models for drug discovery / Markus H. Kuehn, Wei Zhu, editors.

9783031423499 (electronic bk.)
3031423496 (electronic bk.)
9783031423482
3031423488

Cham : Springer, 2023.

English

1 online resource (viii, 332 pages) : illustrations (some color).

10.1007/978-3-031-42349-9 doi

QH588.S83

616.02/774

Since their development a decade ago, human induced pluripotent stem cells (iPSC) have revolutionized the study of human disease, given rise to regenerative medicine technologies, and provided exceptional opportunities for pharmacologic research. These cells provide an essentially unlimited supply of cell types that are difficult to obtain from patients, such as neurons or cardiomyocytes, or are difficult to maintain in primary cell culture. iPSC can be obtained from patients afflicted with a particular disease but, in combination with recently developed gene editing techniques, can also be modified to generate disease models. Moreover, the new techniques of 3 Dimensional printing and materials science facilitate the generation of organoids that can mirror organs under disease conditions. These properties make iPSC powerful tools to study how diseases develop and how they may be treated. In addition, iPSC can also be used to treat conditions in which the target cell population has been lost and such regenerative approaches hold great promise for currently untreatable diseases, including cardiac failure or photoreceptor degenerations.

Access limited to authorized users.

Online resource; title from PDF title page (SpringerLink, viewed November 30, 2023).

Handbook of experimental pharmacology ; v. 281. 1865-0325

Print version: 9783031423482

Online Resources > Ebooks
All Resources